China Approves Another Covid-19 Vax for Emergency Use

Emergency use of a self-developed recombinant protein subunit vaccine against Covid-19 has been approved by China, said the Institute of Microbiology under the Chinese Academy of Sciences.

The vaccine (CHO Cells) completed phase-1 and //phase-2 clinical trials in October 2020. Results support the safety and immunogenicity of this vaccine, with no severe adverse reactions reported.

Prime Minister Narendra Modi Receives His 1st Covid Vaccine Dose
Narendra Modi has received the first dose of Covid vaccine here at All India Institute of Medical Sciences (AIIMS).

‘The patented vaccine is the world's first Covid-19 recombinant protein subunit vaccine approved for clinical research permit and the fourth Covid-19 vaccine approved for emergency use in China.’

Tweet it Now

The level of neutralising antibody elicited by the vaccine is comparable to other Covid-19 recombinant protein vaccines and mRNA vaccines in the world, according to an institute statement, the Xinhua news agency reported.

Researchers have been holding phase-3 trials since November 2020 in China, Uzbekistan, Pakistan, Ecuador and Indonesia, planning to enroll up to 29,000 adults.

Uzbekistan approved the use of the Chinese vaccine on March 1, and China issued emergency use authorisation on March 10.

Novavax's COVID Vaccine Found Effective in Final Trial Analysis
Novavax's COVID-19 shot found to be 96.4% effective against mild, moderate and severe symptoms of COVID-19 in the final analysis of a late-stage trial in the U.K.

Recombinant protein subunit vaccine does not need a high-grade biosafety laboratory for manufacture, and can quickly achieve large-scale production. It is more cost-efficient and easier to store and transport, the vaccine maker said.

Jointly developed by the institute and Anhui Zhifei Longcom Biopharmaceutical Co. Ltd., the patented vaccine is the world's first Covid-19 recombinant protein subunit vaccine approved for clinical research permit and the fourth Covid-19 vaccine approved for emergency use in China.

WHO Experts to Provide Guidelines on Moderna's COVID Vaccine
World Health Organization (WHO) panel of vaccine experts is set to issue recommendations on Moderna's COVID-19 vaccine on Tuesday.

Source-IANS

Over 100 Million COVID Vaccine Doses Administered in US, Says CDC
Across the US, more than 100 million COVID-19 vaccine doses have been administered, according to the latest data of the US Centers for Disease Control and Prevention (CDC).